Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Climent

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Acta Otorrinolaringologica Espanola|March 29, 2001
[Experience in the treatment of 98 carcinomas of the nasopharynx. Long-term follow-up and analysis of prognostic factors]C Gaspar, E Zapater, M Chust, et al.
British Journal of Cancer|March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancerX Garcia del Muro, E Marcuello, J Gumá, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2022
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upJ Oldenburg, D M Berney, C Bokemeyer, et al.
Revista Clinica Espanola|April 1, 1993
[The clinico-mammographic follow-up of breast cancer after conservative treatment]M A Climent Durán, A Gómez Gómez, M A Seguí Palmer, et al.
Anticancer Research|May 15, 1998
p53 oncoprotein as a prognostic indicator in patients with breast cancerR Molina, M A Segui, M A Climent, et al.
Actas Urologicas Espanolas|July 22, 2004
[Usefulness of serum markers in renal cell carcinoma]J Rubio Briones, I Iborra Juan, E Aznar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancerJ Tabernero, M A Climent, A Lluch, et al.
Cancer Metastasis Reviews|August 1, 2015
New advances in genitourinary cancer: evidence gathered in 2014C Suárez, J Puente, E Gallardo, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Acta Otorrinolaringologica Espanola|March 29, 2001
[Experience in the treatment of 98 carcinomas of the nasopharynx. Long-term follow-up and analysis of prognostic factors]C Gaspar, E Zapater, M Chust, et al.
British Journal of Cancer|March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancerX Garcia del Muro, E Marcuello, J Gumá, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2022
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upJ Oldenburg, D M Berney, C Bokemeyer, et al.
Revista Clinica Espanola|April 1, 1993
[The clinico-mammographic follow-up of breast cancer after conservative treatment]M A Climent Durán, A Gómez Gómez, M A Seguí Palmer, et al.
Anticancer Research|May 15, 1998
p53 oncoprotein as a prognostic indicator in patients with breast cancerR Molina, M A Segui, M A Climent, et al.
Actas Urologicas Espanolas|July 22, 2004
[Usefulness of serum markers in renal cell carcinoma]J Rubio Briones, I Iborra Juan, E Aznar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancerJ Tabernero, M A Climent, A Lluch, et al.
Cancer Metastasis Reviews|August 1, 2015
New advances in genitourinary cancer: evidence gathered in 2014C Suárez, J Puente, E Gallardo, et al.
Pageof 5